BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,953,083 | +32.0% | 51,751 | +59.4% | 0.01% | +28.6% |
| Q2 2023 | $1,479,288 | +21.8% | 32,469 | +8.4% | 0.01% | +16.7% |
| Q1 2023 | $1,214,813 | -51.7% | 29,951 | -39.3% | 0.01% | -50.0% |
| Q4 2022 | $2,512,974 | -56.3% | 49,303 | -53.9% | 0.01% | -60.0% |
| Q3 2022 | $5,757,000 | -19.9% | 106,882 | -4.5% | 0.03% | -14.3% |
| Q2 2022 | $7,188,000 | -24.3% | 111,909 | -8.6% | 0.04% | -10.3% |
| Q1 2022 | $9,491,000 | -9.9% | 122,407 | -0.3% | 0.04% | -4.9% |
| Q4 2021 | $10,535,000 | +9.7% | 122,723 | +2.8% | 0.04% | -2.4% |
| Q3 2021 | $9,606,000 | +0.8% | 119,428 | +0.9% | 0.04% | 0.0% |
| Q2 2021 | $9,529,000 | -5.6% | 118,371 | -1.1% | 0.04% | -10.6% |
| Q1 2021 | $10,093,000 | +5.1% | 119,672 | -0.0% | 0.05% | 0.0% |
| Q4 2020 | $9,605,000 | +2.4% | 119,704 | +2.7% | 0.05% | -9.6% |
| Q3 2020 | $9,376,000 | -5.3% | 116,582 | +1.4% | 0.05% | -11.9% |
| Q2 2020 | $9,898,000 | +5.6% | 114,964 | -0.4% | 0.06% | -11.9% |
| Q1 2020 | $9,376,000 | -7.1% | 115,478 | -4.3% | 0.07% | +19.6% |
| Q4 2019 | $10,095,000 | -3.5% | 120,723 | +1.0% | 0.06% | -11.1% |
| Q3 2019 | $10,460,000 | +7.4% | 119,581 | +0.5% | 0.06% | +5.0% |
| Q2 2019 | $9,740,000 | +3.1% | 118,929 | +2.4% | 0.06% | -1.6% |
| Q1 2019 | $9,444,000 | +22.0% | 116,154 | -1.2% | 0.06% | +8.9% |
| Q4 2018 | $7,742,000 | -34.7% | 117,622 | -23.5% | 0.06% | -25.3% |
| Q3 2018 | $11,852,000 | -46.4% | 153,745 | -48.7% | 0.08% | -50.0% |
| Q2 2018 | $22,111,000 | +17.6% | 299,440 | +3.6% | 0.15% | +17.2% |
| Q1 2018 | $18,797,000 | +14.6% | 289,008 | +13.9% | 0.13% | +14.3% |
| Q4 2017 | $16,400,000 | +1.8% | 253,712 | -1.2% | 0.11% | -2.6% |
| Q3 2017 | $16,106,000 | +6.2% | 256,668 | +2.4% | 0.12% | +2.7% |
| Q2 2017 | $15,171,000 | +385.8% | 250,589 | +316.1% | 0.11% | +366.7% |
| Q1 2017 | $3,123,000 | -17.7% | 60,229 | -29.6% | 0.02% | -22.6% |
| Q4 2016 | $3,795,000 | +2.0% | 85,579 | +9.5% | 0.03% | 0.0% |
| Q3 2016 | $3,721,000 | +4.0% | 78,172 | -1.2% | 0.03% | +3.3% |
| Q2 2016 | $3,578,000 | +3.4% | 79,120 | -6.0% | 0.03% | 0.0% |
| Q1 2016 | $3,460,000 | +35.6% | 84,214 | +25.9% | 0.03% | +36.4% |
| Q4 2015 | $2,552,000 | +1.8% | 66,881 | -12.3% | 0.02% | -4.3% |
| Q3 2015 | $2,506,000 | -49.3% | 76,286 | +7.9% | 0.02% | -46.5% |
| Q2 2015 | $4,946,000 | -19.5% | 70,726 | -21.2% | 0.04% | -18.9% |
| Q1 2015 | $6,145,000 | -43.6% | 89,710 | -39.6% | 0.05% | -43.0% |
| Q4 2014 | $10,892,000 | +1.7% | 148,618 | -0.4% | 0.09% | -5.1% |
| Q3 2014 | $10,708,000 | -3.3% | 149,195 | -2.5% | 0.10% | -2.0% |
| Q2 2014 | $11,068,000 | -8.3% | 153,091 | -6.7% | 0.10% | -11.5% |
| Q1 2014 | $12,069,000 | +18.1% | 164,022 | +11.7% | 0.11% | +14.1% |
| Q4 2013 | $10,215,000 | -5.0% | 146,871 | -10.2% | 0.10% | -10.8% |
| Q3 2013 | $10,749,000 | -8.9% | 163,627 | -3.9% | 0.11% | -11.9% |
| Q2 2013 | $11,799,000 | – | 170,338 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |